Company: IMRX
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001790340-25-000053
Chunk: 2

Company: Immuneering Corp
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 2
---
 (Clawback Policy)                                             |     |   22 |
| Long-Term Incentive Compensation Grant Practices                                           |     |   22 |
| Stockholder Communications with Our Board of Directors                                     |     |   23 |
| EXECUTIVE OFFICER AND DIRECTOR COMPENSATION                                                |     |   24 |
| 2024Summary Compensation Table                                                             |     |   24 |
| Narrative to2024Summary Compensation Table                                                 |     |   24 |
| Outstanding Equity Awards at 2024Fiscal Year-End                                           |     |   27 |
| Executive Compensation Arrangements                                                        |     |   27 |
| Director Compensation                                                                      |     |   29 |
| 2024 Director Compensation Table                                                           |     |   30 |
| EQUITYCOMPENSATION PLAN INFORMATION                                                        |     |   31 |
| STOCK OWNERSHIP                                                                            |     |   32 |
| Security Ownership of Certain Beneficial Owners and Management                             |     |   32 |
| CERTAIN TRANSACTIONS WITH RELATED PERSONS                                                  |     |   34 |
| Policies and Procedures Regarding Transactions with Related Persons                        |     |   34 |
| Certain Related Person Transactions                                                        |     |   34 |
| STOCKHOLDER PROPOSALS AND DIRECTOR NOMINATIONS                                             |     |   35 |
| HOUSEHOLDING OF PROXY MATERIALS                                                            |     |   35 |
| 2024ANNUAL REPORT                                                                          |     |   36 |

TABLE OF CONTENTS

#### Immuneering Corporation

#### 245 Main Street

#### Second Floor

#### Cambridge, MA 02142

### PROXY STATEMENT

### FOR ANNUAL MEETING OF STOCKHOLDERS

#### TO BE HELD ON JUNE 13, 2025
This proxy statement (the “Proxy Statement”) and our annual report for the fiscal year ended December 31, 2024 (the “Annual Report” and, together with the Proxy Statement, the “proxy materials”) are being furnished by and on behalf of the Board of Directors (the “Board of Directors” or “Board”) of Immuneering Corporation (the “Company”, “Immuneering”, “we,” “us” or “our”) in connection with our 2025 annual meeting of stockholders (the “Annual Meeting”). The proxy materials are first being sent on or about April 21, 2025 to all stockholders entitled to notice of and to